… therapy selection and development for Chinese patients. Here we report an … Chinese patients
with non-small cell lung cancer. Tumor-infiltrating lymphocyte estimated using immune cell …

… -standardized mortality rate in China: 40.11/… lung cancer cases in China, 520,300 were
males and 266,700 were females [6]. The incidence of lung cancer was relatively low in Chinese …

… of patients treated with Chinese medicine concurrently with chemotherapy or EGFR-TKIs,
which might be commonly seen in China. Finally, we only described the treatment status and …

… Treatment strategies for non-small cell lung cancer (NSCLC) have been revolutionized
since the identification of EGFR activating mutations which predict response to EGFR tyrosine …

… 14 non–small cell lung carcinomas (NSCLCs) with matched adjacent normal lung tissues
extracted from Chinese patients. … for treating non–small cell lung cancer, especially in Chinese. …

… efficacy and safety of using Chinese herbal medicine (CHM) as maintenance therapy
considering the survival of advanced non-small-cell lung cancer (NSCLC) patients after first-line …

… In conclusion, BRAF mutation in Chinese patients with NSCLC was rare. BRAF mutation is
more likely to be associated with adenocarcinoma and never smokers. BRAF mutations are …

… The aim was to evaluate the effects of traditional Chinese medicine (… non-small cell lung
cancer (NSCLC) patients. The 314 patients with completely resected stage IB, II or IIIA cancers …

Background Adjuvant chemotherapy after radical resection of stage IIIA non-small-cell lung
cancer (NSCLC) has quite poor outcomes. We aimed to investigate whether adjuvant …

… in China. This paper studied the characteristics of NSCLC patients in the biggest hospital in
Northwest China … may contribute to the prevention and treatment of NSCLC as wells as the …